ArticleJournal of the Chinese Medical Association : JCMA2022

Sofosbuvir-based antiviral therapy provided highly treatment efficacy, safety, and good tolerability for Taiwanese chronic hepatitis C patients with decompensated cirrhosis.

Pin-Shuo Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.